1 mg
BioServUK offers a series of different monoclonal antibodies for the detection of the SARS-CoV-2. All antibodies come from hybridoma cell lines that were generated by immunization with the recombinant full-length Spike protein (S) or the receptor-binding domain.
This antibody has been validated by ELISA and is specifically directed against an epitope that is located within the S1-subunit but outside the RBD. It is produced exclusively under serum‐free conditions form hybridoma and purified through one-step purification with Protein-A affinity chromatography.